Welcome to LookChem.com Sign In|Join Free

CAS

  • or

29274-13-3

Post Buying Request

29274-13-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

29274-13-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 29274-13-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,2,7 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 29274-13:
(7*2)+(6*9)+(5*2)+(4*7)+(3*4)+(2*1)+(1*3)=123
123 % 10 = 3
So 29274-13-3 is a valid CAS Registry Number.

29274-13-3Relevant articles and documents

In silico design of novel probes for the atypical opioid receptor MRGPRX2

Lansu, Katherine,Karpiak, Joel,Liu, Jing,Huang, Xi-Ping,McCorvy, John D.,Kroeze, Wesley K.,Che, Tao,Nagase, Hiroshi,Carroll, Frank I.,Jin, Jian,Shoichet, Brian K.,Roth, Bryan L.

, p. 529 - 536 (2017)

The primate-exclusive MRGPRX2 G protein-coupled receptor (GPCR) has been suggested to modulate pain and itch. Despite putative peptide and small-molecule MRGPRX2 agonists, selective nanomolar-potency probes have not yet been reported. To identify a MRGPRX

Evaluation of novel 7-(hetero)aryl-substituted pyrazolo[1, 5-a]pyrimidines as phosphodiesterase-4 inhibitors

Kodimuthali Arumugam,Gupta, Rajesh,Parsa, Kishore Venkata Laxmi,Prasunamba, Padala Lakshmi,Pal, Manojit

scheme or table, p. 402 - 408 (2011/10/18)

A novel series of 7-(hetero)aryl substituted-pyrazolopyrimidines, prepared via an AlCl3 induced C-C bond forming reaction of 7-chloro-5-phenyl-pyrazolo[1,5-a]pyrimidine with arenes and heteroarenes have been investigated as PDE4 inhibitors. Amo

PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS

-

Page/Page column 34, (2008/06/13)

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 29274-13-3